Global Study of MK-2060 in Participants With End Stage Renal Disease Receiving Hemodialysis
The purpose of this study is to evaluate the efficacy and safety of two different doses of MK-2060 (a monoclonal antibody against Factor XI) in end stage renal disease (ESRD) participants